Innoviva CFO reports 1,244-share tax disposition

Innoviva, Inc. Chief Financial Officer Stephen Basso reported a tax-related share disposition.

Accepted by SEC EDGAR 02/24/2026 - 04:15 PM EST Learn about SEC filing dates

Rhea-AI Filing Summary

Innoviva, Inc. Chief Financial Officer Stephen Basso reported a tax-related share disposition. On February 20, 2026, 1,244 shares of common stock were withheld by the company at $23.39 per share to satisfy income tax obligations on vesting equity awards. After this withholding, Basso directly owns 50,013 shares of Innoviva common stock.

Insider Trade Summary

Exercise Price or Tax Liability: 1,244 shares

Exercise Price or Tax Liability 1 txn

Insider Basso Stephen

Role Chief Financial Officer

Type	Security	Shares	Price	Value
Exercise Price or Tax Liability	Common Stock	1,244	$23.39	$29K

Holdings After Transaction: Common Stock — 50,013 shares (Direct)

Holdings Before and After: Common Stock, 51,257 to 50,013 shares (Direct)

Footnotes (1)

1. F1. The shares were withheld by the Issuer to satisfy income tax withholding obligations associated with the quarterly vesting of previously granted employee equity grants.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Innoviva (INVA) disclose for Stephen Basso?

Innoviva disclosed that CFO Stephen Basso had 1,244 common shares withheld on February 20, 2026. The shares were used to cover income tax obligations from the quarterly vesting of previously granted employee equity awards, rather than an open-market sale.

Was the Innoviva (INVA) CFO’s Form 4 transaction an open-market stock sale?

No, the transaction was not an open-market sale. Innoviva withheld 1,244 shares from CFO Stephen Basso to satisfy income tax withholding obligations tied to the vesting of existing equity grants, a routine administrative disposition for tax purposes.

How many Innoviva (INVA) shares were involved in the CFO’s tax-withholding disposition?

The Form 4 shows 1,244 Innoviva common shares were withheld. The price reported was $23.39 per share, reflecting shares delivered back to the company to satisfy the CFO’s income tax obligations on vested equity awards.

How many Innoviva (INVA) shares does CFO Stephen Basso hold after this Form 4 event?

After the tax-withholding disposition, CFO Stephen Basso directly owns 50,013 shares of Innoviva common stock. This figure reflects his remaining direct holdings following the 1,244 shares withheld by the company to cover equity-related tax obligations.

What does transaction code "F" mean in the Innoviva (INVA) Form 4 filing?

Transaction code “F” indicates payment of an exercise price or tax liability by delivering securities. In this Innoviva filing, 1,244 shares were withheld from CFO Stephen Basso to satisfy income tax withholding obligations from the vesting of employee equity grants.

What was the reported price per share in the Innoviva (INVA) CFO’s Form 4 transaction?

The Form 4 reports a price of $23.39 per Innoviva common share. This price applies to the 1,244 shares withheld by the company from CFO Stephen Basso to cover his income tax obligations on quarterly vesting equity awards.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Basso Stephen

(Last) (First) (Middle)

1350 OLD BAYSHORE HIGHWAY, SUITE 400

(Street)

BURLINGAME CA 94010

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Innoviva, Inc. [ INVA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

3. Date of Earliest Transaction (Month/Day/Year)
02/20/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/20/2026		F		1,244(1)	D	$23.39	50,013	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The shares were withheld by the Issuer to satisfy income tax withholding obligations associated with the quarterly vesting of previously granted employee equity grants.

	/s/ Stephen Basso	02/24/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.